ArticleCancer2021

Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation.

Erica D Warlick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.